|
2022
|
Invention
|
Aminoadamantyl nitrate compounds and their use to treat cns disorders. The present disclosure pro... |
|
2008
|
Invention
|
Andrographolide derivatives and use thereof in manufacture of medicaments. Pseudomonas aeruginosa... |
|
|
Invention
|
Andrographolide derivatives and use thereof in manufacture of medicaments. The present invention ... |
|
2005
|
Invention
|
Aminoadamantane derivatives as therapeutic agents. The present invention provides novel aminoadam... |
|
|
Invention
|
Cc-1065 analogues for use against cancers. The present invention relates to novel CC-1065 derivat... |
|
2004
|
Invention
|
Antioxidant nitroxides and nitrones as therapeutic agents. 8 is amino, the compounds are the free... |
|
|
Invention
|
Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to ind... |
|
2003
|
Invention
|
Novel anticancer conjugates of camptothecin and unsaturated fatty acids. The present invention pr... |
|
|
Invention
|
Anticancer conjugates of camptothecin and unsaturated fatty acids. The present invention provides... |
|
2002
|
Invention
|
Antioxidant nitroxides and nitrones as therapeutic agents. The invention provides novel adamantan... |
|
2001
|
Invention
|
Novel amino acid and peptide inhibitors of staphylococcus virulence. Isolated synthetic modified ... |
|
|
Invention
|
Circularly permutated, interaction-activated proteins. Interaction-activated circularly permutate... |
|
2000
|
Invention
|
A general method for optimizing the expression of heterologous proteins. Methods are disclosed wh... |
|
|
Invention
|
Interaction-activated proteins. Fragment pairs of a Class A β-lactamase (TEM-1 of E. coli are dis... |
|
|
Invention
|
Assay for asymmetrical dimethyl-l-arginine (adma). ADMA is determined in a physiological sample b... |
|
1999
|
Invention
|
Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity. Compos... |
|
1998
|
Invention
|
Methods and compositions for the treatment and prevention of staphylococcus aureus infections. Me... |
|
|
Invention
|
Cardiovascular disease risk assessment. Improved cardiovascular risk assessment is achieved by de... |
|
1997
|
Invention
|
Assay for inhibitors of a 24 kd cytoplasmic protease which activates dna fragmentation in apoptos... |
|
1996
|
Invention
|
Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents. The pre... |
|
1995
|
Invention
|
A 24 kilodalton cytoplasmic protease activating dna fragmentation apoptosis. A 24 kilodalton cyto... |
|
1994
|
Invention
|
Methods and compositions for detecting lipopolysaccharides using cap18 fragments. Compositions an... |
|
|
Invention
|
Use of esculentoside a for treatment of lipopolysaccharide and macrophage mediated disorders. Esc... |
|
|
Invention
|
24 kilodalton cytoplasmic protease activating dna fragmentation in apoptosis. An apoptosis-associ... |
|
1992
|
Invention
|
Hepatokine and methods for its use. A novel human hepatokine, referred to hereinafter as HPX, has... |
